CYP2C19 polymorphism is a major predictor of treatment failure in white patients by use of lansoprazole-based quadruple therapy for eradication of Helicobacter pylori.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples